• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向逆转录病毒整合以实现更安全基因治疗的策略:进展与挑战

Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

作者信息

Yoder Kristine E, Rabe Anthony J, Fishel Richard, Larue Ross C

机构信息

Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, United States.

出版信息

Front Mol Biosci. 2021 May 12;8:662331. doi: 10.3389/fmolb.2021.662331. eCollection 2021.

DOI:10.3389/fmolb.2021.662331
PMID:34055882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8149907/
Abstract

Retroviruses are obligate intracellular parasites that must integrate a copy of the viral genome into the host DNA. The integration reaction is performed by the viral enzyme integrase in complex with the two ends of the viral cDNA genome and yields an integrated provirus. Retroviral vector particles are attractive gene therapy delivery tools due to their stable integration. However, some retroviral integration events may dysregulate host oncogenes leading to cancer in gene therapy patients. Multiple strategies to target retroviral integration, particularly to genetic safe harbors, have been tested with limited success. Attempts to target integration may be limited by the multimerization of integrase or the presence of host co-factors for integration. Several retroviral integration complexes have evolved a mechanism of tethering to chromatin via a host protein. Integration host co-factors bind chromatin, anchoring the complex and allowing integration. The tethering factor allows for both close proximity to the target DNA and specificity of targeting. Each retrovirus appears to have distinct preferences for DNA sequence and chromatin features at the integration site. Tethering factors determine the preference for chromatin features, but do not affect the subtle sequence preference at the integration site. The sequence preference is likely intrinsic to the integrase protein. New developments may uncouple the requirement for a tethering factor and increase the ability to redirect retroviral integration.

摘要

逆转录病毒是专性细胞内寄生虫,必须将病毒基因组的一个拷贝整合到宿主DNA中。整合反应由病毒酶整合酶与病毒cDNA基因组的两端形成复合物来进行,产生一个整合的前病毒。逆转录病毒载体颗粒因其稳定整合而成为有吸引力的基因治疗递送工具。然而,一些逆转录病毒整合事件可能会使宿主癌基因失调,从而在基因治疗患者中导致癌症。针对逆转录病毒整合,特别是针对基因安全港的多种策略已经进行了测试,但取得的成功有限。靶向整合的尝试可能会受到整合酶多聚化或整合所需宿主辅助因子的存在的限制。几种逆转录病毒整合复合物已经进化出一种通过宿主蛋白与染色质连接的机制。整合宿主辅助因子结合染色质,锚定复合物并允许整合。连接因子既允许与靶DNA紧密接近,又允许靶向特异性。每种逆转录病毒似乎对整合位点的DNA序列和染色质特征都有不同的偏好。连接因子决定了对染色质特征的偏好,但不影响整合位点处微妙的序列偏好。序列偏好可能是整合酶蛋白固有的。新的进展可能会解除对连接因子的需求,并提高重新定向逆转录病毒整合的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/59c825a363f6/fmolb-08-662331-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/097c335fe83f/fmolb-08-662331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/54fba0213ed0/fmolb-08-662331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/7e5a1f847f99/fmolb-08-662331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/881ecbb3bc3d/fmolb-08-662331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/59c825a363f6/fmolb-08-662331-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/097c335fe83f/fmolb-08-662331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/54fba0213ed0/fmolb-08-662331-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/7e5a1f847f99/fmolb-08-662331-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/881ecbb3bc3d/fmolb-08-662331-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fb/8149907/59c825a363f6/fmolb-08-662331-g005.jpg

相似文献

1
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.靶向逆转录病毒整合以实现更安全基因治疗的策略:进展与挑战
Front Mol Biosci. 2021 May 12;8:662331. doi: 10.3389/fmolb.2021.662331. eCollection 2021.
2
Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75.HIV-1 整合酶固有染色质结合特性的调制作用由 LEDGF/p75 介导。
Nucleic Acids Res. 2021 Nov 8;49(19):11241-11256. doi: 10.1093/nar/gkab886.
3
Mechanisms governing lentivirus integration site selection.慢病毒整合位点选择的调控机制。
Curr Gene Ther. 2008 Dec;8(6):419-29. doi: 10.2174/156652308786848021.
4
Retroviral DNA integration: HIV and the role of LEDGF/p75.逆转录病毒DNA整合:HIV与LEDGF/p75的作用
Trends Genet. 2006 Jul;22(7):388-95. doi: 10.1016/j.tig.2006.05.006. Epub 2006 May 26.
5
Chromatin tethering and retroviral integration: recent discoveries and parallels with DNA viruses.染色质束缚与逆转录病毒整合:近期发现及与DNA病毒的相似之处
Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):182-91. doi: 10.1016/j.bbagrm.2009.10.001. Epub 2009 Oct 15.
6
Molecular mechanisms of retroviral integration site selection.逆转录病毒整合位点选择的分子机制。
Nucleic Acids Res. 2014;42(16):10209-25. doi: 10.1093/nar/gku769. Epub 2014 Aug 21.
7
Host factors for retroviral integration site selection.逆转录病毒整合位点选择的宿主因素。
Trends Biochem Sci. 2015 Feb;40(2):108-16. doi: 10.1016/j.tibs.2014.12.001. Epub 2014 Dec 31.
8
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor.利用工程化的拴系因子在体外调节人类免疫缺陷病毒DNA整合过程中的靶位点选择。
Hum Gene Ther. 2006 Sep;17(9):960-7. doi: 10.1089/hum.2006.17.960.
9
Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.病毒进化揭示了LEDGF/p75在HIV染色体拴系中的独特作用。
PLoS Pathog. 2007 Mar;3(3):e47. doi: 10.1371/journal.ppat.0030047.
10
Retroviral integration site selection.逆转录病毒整合位点选择。
Viruses. 2010 Jan;2(1):111-130. doi: 10.3390/v2010111. Epub 2010 Jan 12.

引用本文的文献

1
Adeno-associated virus vector modification based on directed evolution technology for gene therapy targeting head and neck squamous cell carcinoma.基于定向进化技术的腺相关病毒载体修饰用于头颈部鳞状细胞癌的基因治疗
Front Oncol. 2025 Jun 3;15:1566584. doi: 10.3389/fonc.2025.1566584. eCollection 2025.
2
Development and validation of optimized lentivirus-like particles for gene editing tool delivery with Gag-Only strategy.采用仅含Gag策略开发和验证用于基因编辑工具递送的优化类慢病毒颗粒。
Eur J Med Res. 2025 Apr 4;30(1):242. doi: 10.1186/s40001-025-02499-2.
3
Clinical and Translational Landscape of Viral Gene Therapies.

本文引用的文献

1
Optimization of AAV vectors to target persistent viral reservoirs.优化 AAV 载体以靶向持续性病毒储存库。
Virol J. 2021 Apr 23;18(1):85. doi: 10.1186/s12985-021-01555-7.
2
Delivering AAV to the Central Nervous and Sensory Systems.将 AAV 递送至中枢神经系统和感觉系统。
Trends Pharmacol Sci. 2021 Jun;42(6):461-474. doi: 10.1016/j.tips.2021.03.004. Epub 2021 Apr 13.
3
Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.最佳可能世界:基于细小病毒和异源病毒的混合基因治疗载体。
病毒基因治疗的临床和转化前景。
Cells. 2024 Nov 19;13(22):1916. doi: 10.3390/cells13221916.
4
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.工程诱导性白血病相关融合蛋白可实现大规模体外生产功能性人吞噬细胞。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2312499121. doi: 10.1073/pnas.2312499121. Epub 2024 Jun 10.
5
Advances in HIV Gene Therapy.HIV基因治疗的进展
Int J Mol Sci. 2024 Feb 28;25(5):2771. doi: 10.3390/ijms25052771.
6
DNA strand breaks and gaps target retroviral intasome binding and integration.DNA 链断裂和缺口靶向逆转录病毒整合酶复合物结合和整合。
Nat Commun. 2023 Nov 3;14(1):7072. doi: 10.1038/s41467-023-42641-4.
7
Data-mining unveils structure-property-activity correlation of viral infectivity enhancing self-assembling peptides.数据挖掘揭示了病毒感染增强型自组装肽的结构-性质-活性相关性。
Nat Commun. 2023 Aug 23;14(1):5121. doi: 10.1038/s41467-023-40663-6.
8
Nanoporous electroporation needle for localized intracellular delivery in deep tissues.用于深部组织局部细胞内递送的纳米多孔电穿孔针
Bioeng Transl Med. 2022 Dec 8;8(4):e10418. doi: 10.1002/btm2.10418. eCollection 2023 Jul.
9
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.BET 溴结构域抑制剂:新颖的设计策略和治疗应用。
Molecules. 2023 Mar 29;28(7):3043. doi: 10.3390/molecules28073043.
10
Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV-Based Vectors and for a Cure for HIV-1 Infection.逆转录病毒整合的决定因素及其对基于 MLV 的基因治疗载体和 HIV-1 感染治愈的影响。
Viruses. 2022 Dec 21;15(1):32. doi: 10.3390/v15010032.
Mol Ther. 2021 Dec 1;29(12):3359-3382. doi: 10.1016/j.ymthe.2021.04.005. Epub 2021 Apr 5.
4
Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions.腺相关病毒(AAV)载体的细胞内运输:挑战与未来方向
Gene Ther. 2021 Dec;28(12):683-696. doi: 10.1038/s41434-021-00243-z. Epub 2021 Mar 3.
5
Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation.靶向髓系恶性肿瘤及其他疾病中的染色质复合物:从基础机制到临床创新。
Cells. 2020 Dec 21;9(12):2721. doi: 10.3390/cells9122721.
6
Clustering and reverse transcription of HIV-1 genomes in nuclear niches of macrophages.HIV-1 基因组在巨噬细胞核小体中的聚类和逆转录。
EMBO J. 2021 Jan 4;40(1):e105247. doi: 10.15252/embj.2020105247. Epub 2020 Dec 3.
7
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus.慢病毒载体假型化:衣如其人,亦如其“毒”。
Viruses. 2020 Nov 16;12(11):1311. doi: 10.3390/v12111311.
8
Cryo-EM structure of the deltaretroviral intasome in complex with the PP2A regulatory subunit B56γ.德尔塔逆转录病毒整合酶-辅助蛋白复合物的冷冻电镜结构,与蛋白磷酸酶 2A 的调节亚基 B56γ 结合。
Nat Commun. 2020 Oct 7;11(1):5043. doi: 10.1038/s41467-020-18874-y.
9
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus.抗逆转录病毒治疗无法抑制的 HIV-1 病毒血症可能来源于产生感染性病毒的大 T 细胞克隆。
J Clin Invest. 2020 Nov 2;130(11):5847-5857. doi: 10.1172/JCI138099.
10
The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.《旧与新:非整合慢病毒载体技术的前景》。
Viruses. 2020 Sep 29;12(10):1103. doi: 10.3390/v12101103.